Advertisement

Molecular and Cellular Biochemistry

, Volume 426, Issue 1–2, pp 87–99 | Cite as

Articulatin-D induces apoptosis via activation of caspase-8 in acute T-cell leukemia cell line

  • Ruchi Mishra
  • Mrinal K. Das
  • Savita Singh
  • Radhey Shyam Sharma
  • Sadhna Sharma
  • Vandana Mishra
Article

Abstract

Leukemia is among the most aggressive and prevalent human malignant carcinoma. Chemotherapy is the preferred therapeutic strategy; however, recurrence of cancer and non-selective cytotoxicity are the major concerns. Unlike synthetic chemotherapeutic agents, mistletoe ribosome-inactivating protein (RIP) displays anti-tumor function in various types of cancers. However, its effect on leukemia cells is little explored. In this study, we assessed the impact of Viscum articulatum RIP (Articulatin-D) on the survival of acute T-cell leukemia cells and the involved molecular and cellular mechanisms. Cell proliferation assay showed that Articulatin-D suppressed the viability of leukemia cells selectively. We further confirmed that the elevation of mitochondrial membrane potential and exposure of phosphatidylserine are the early events of apoptosis induction in Articulatin-D-treated Jurkat cells. Subsequently, we found that Articulatin-D treatment induces apoptosis in Jurkat cells in a time- and concentration-dependent manner. In conclusion, we provided evidence that Articulatin-D efficiently activates caspase-8 involved in extrinsic pathway of apoptosis induction, which ultimately results in caspase-3-dependent DNA fragmentation of Jurkat cells. Further evaluation of Articulatin-D in cell culture and animal models may provide novel information on selective cytotoxicity to acute T-cell leukemia and its involvement in targeting tumor cell survival pathways.

Keywords

Viscum articulatum (mistletoeAnticancer Ribosome-inactivating protein Apoptosis mechanism Leukemia cell line Articulatin-D 

Notes

Acknowledgements

Authors thank the University of Delhi for Faculty research grant to VM, Miranda House for Flow Cytometer facility of the DS Kothari Centre for Research and Innovation in Science Education. RM thanks the University Grant Commission for JRF for Ph.D. and SS thanks the UGC for Non-NET Research Fellowship. Authors thank Professor Millind Sardesai for all support throughout the study.

References

  1. 1.
    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMedGoogle Scholar
  2. 2.
    Gaynon PS (2005) Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol 131:579–587CrossRefPubMedGoogle Scholar
  3. 3.
    Lichtman MA (2008) Battling the hematological malignancies: the 200 years’ war. Oncologist 13:126–138CrossRefPubMedGoogle Scholar
  4. 4.
    Voliotis D, Diehl V (2002) Challenges in treating hematologic malignancies. Semin Oncol 29:30–39CrossRefPubMedGoogle Scholar
  5. 5.
    Siegel R, Desantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E (2013) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241CrossRefGoogle Scholar
  6. 6.
    Vagace JM, Gervasini G (2010) Chemotherapy toxicity in patients with acute leukemia—The scientist’s perspective and challenge. Available from http://www.intechopen.com/books/acute-leukemia-the-scientist-sperspective-and-challenge/chemotherapy-toxicity-in-patients-with-acute-leukemia
  7. 7.
    Pryme IF, Bardocz S, Pusztai A, Ewen SWB (2006) Suppression of growth of tumour cell lines in vitro and tumours in vivo by mistletoe lectins. Histol Histopathol 21:285–299PubMedGoogle Scholar
  8. 8.
    Grossarth-Maticek R, Ziegler R (2006) Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis. Eur J Med Res 11:485–495PubMedGoogle Scholar
  9. 9.
    Goebell PJ, Thomas O, Julia S, Herbert R (2002) Evaluation of an unconventional treatment modality with Mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial. J Urol 168:72–75CrossRefPubMedGoogle Scholar
  10. 10.
    Bar-Sela G, Haim N (2004) Abnoba-viscum (Mistletoe extract) in metastatic colorectal carcinoma resistant to 5-fluorouracil and leucovorin-based chemotherapy. Med Oncol 21:251–254CrossRefPubMedGoogle Scholar
  11. 11.
    Bar-Sela G, Wollner M, Hammer L, Agbarya A, Dudnik E, Haim N (2013) Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study. Eur J Cancer 49:1058–1064CrossRefPubMedGoogle Scholar
  12. 12.
    Horneber M, Bueschel G, Huber R, Linde K, Rostock M (2010) Mistletoe therapy in oncology. Cochrane Libr 4:4–6Google Scholar
  13. 13.
    Stirpe F, Battelli MG (2006) Ribosome-inactivating proteins: progress and problems. Cell Mol Life Sci 63:1850–1866CrossRefPubMedGoogle Scholar
  14. 14.
    Büssing A (1996) Induction of apoptosis by the mistletoe lectins: a review on the mechanisms of cytotoxicity mediated by Viscum album L. Apoptosis 1:25–32CrossRefGoogle Scholar
  15. 15.
    Mishra V, Sharma RS, Yadav S, Babu CR, Singh TP (2004) Purification and characterization of four isoforms of Himalayan mistletoe ribosome-inactivating protein from Viscum album having unique sugar affinity. Arch Biochem Biophys 423:288–301CrossRefPubMedGoogle Scholar
  16. 16.
    Mishra V, Ethayathulla AS, Sharma RS, Yadav S, Krauspenhaar R, Betzel C, Babu CR, Singh TP (2004) Structure of a novel ribosome-inactivating protein from a hemi-parasitic plant inhabiting the northwestern Himalayas. Acta Crystallogr D Biol Crystallogr 60:2295–2304CrossRefPubMedGoogle Scholar
  17. 17.
    Mishra V, Bilgrami S, Sharma RS, Kaur P, Yadav S, Krauspenhaar R, Betzel C, Voelter W, Babu CR, Singh TP (2005) Crystal structure of himalayan mistletoe ribosome-inactivating protein reveals the presence of a natural inhibitor and a new functionally active sugar-binding site. J Biol Chem 280:20712–20721CrossRefPubMedGoogle Scholar
  18. 18.
    Das MK, Sharma RS, Mishra V (2011) A cytotoxic type-2 ribosome inactivating protein (from leafless mistletoe) lacking sugar binding activity. Int J Biol Macromol 49:1096–1103CrossRefPubMedGoogle Scholar
  19. 19.
    Das MK, Sharma RS, Mishra V (2012) Induction of apoptosis by ribosome inactivating proteins. Appl Biochem Biotechnol 166:1552–1561CrossRefPubMedGoogle Scholar
  20. 20.
    Shanavaskhan AE, Sivadasan M, Alfarhan AH, Thomas J (2012) Ethnomedicinal aspects of angiospermic epiphytes and parasites of Kerala, India. Indian J Tradit Knowl 11:250–258Google Scholar
  21. 21.
    Singh H, Krishna G, Baske PK (2010) Plants used in the treatment of joint diseases (rheumatism, arthritis, gout and lumbago) in Mayurbhanj district of Odisha, India. Rep Opin 2:22–26Google Scholar
  22. 22.
    Pradhan BK, Badola HK (2008) Ethnomedicinal plant use by Lepcha tribe of Dzongu valley, bordering Khangchendzonga biosphere reserve, in north Sikkim, India. J Ethnobiol Ethnomed 4:22CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Wiart C (2012) Medicinal plants of China, Korea, and Japan: bioresources for tomorrow’s drugs and cosmetics. Taylor & Francis, Boca RatonCrossRefGoogle Scholar
  24. 24.
    Liu Y (1986) Pharmaceutical composition for treating nonlymphatic leukemia and method of producing the same and its components. Chem Abstr 106:90200jGoogle Scholar
  25. 25.
    Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMedGoogle Scholar
  26. 26.
    Vermes I, Haanen Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39–51CrossRefPubMedGoogle Scholar
  27. 27.
    Battelli MG, Citores L, Buonamici L, Ferreras JM, De Benito FM, Stirpe F, Girbés T (1997) Toxicity and cytotoxicity of nigrin b, a two-chain ribosome-inactivating protein from Sambucus nigra: comparison with ricin. Arch Toxicol 71:360–364CrossRefPubMedGoogle Scholar
  28. 28.
    Ayyagari VN, Brard L (2014) Bithionol inhibits ovarian cancer cell growth in vitro-studies on mechanism(s) of action. BMC Cancer 14:61–77CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Ding X, Zhu FS, Li M, Gao SG (2012) Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L. J Ethnopharmacol 139:599–604CrossRefPubMedGoogle Scholar
  30. 30.
    Gercel-Taylor C (2005) Diphenylamine assay of DNA fragmentation for chemosensitivity testing. Methods Mol Med 111:79–82PubMedGoogle Scholar
  31. 31.
    Sikriwal D, Batra JK (2010) Ribosome inactivating proteins and apoptosis. Plant Cell Monogr 18:167–189CrossRefGoogle Scholar
  32. 32.
    Saxena N, Yadav P, Kumar O (2013) The Fas/Fas ligand apoptotic pathway is involved in abrin-induced apoptosis. Toxicol Sci 135:103–118CrossRefPubMedGoogle Scholar
  33. 33.
    Bantel H, Engels IH, Voelter W, Klaus SO, Sebastian W (1999) Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res 59:2083–2090PubMedGoogle Scholar
  34. 34.
    Narayanan S, Surolia A, Karande A (2004) Ribosome-inactivating protein and apoptosis: abrin causes cell death via mitochondrial pathway in Jurkat cells. Biochem J 377:233–240CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Hickman JA (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11:21–139CrossRefGoogle Scholar
  37. 37.
    Perl A, Gergely PJ, Nagy G, Koncz A, Banki K (2004) Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol 25:360–367CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Sánchez-Alcázar J, Ault J, Khodjakov A, Schneider E (2000) Increased mitochondrial cytochrome c levels and mitochondrial hyperpolarization precede camptothecin-induced apoptosis in Jurkat cells. Cell Death Differ 7:1090–1100CrossRefPubMedGoogle Scholar
  39. 39.
    Scarlett JL, Sheard PW, Hughes G, Ledgerwood EC, Ku HH, Murphy MP (2000) Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett 475:267–272CrossRefPubMedGoogle Scholar
  40. 40.
    Vander Heiden MG, Chandel NS, Li XX, Schumacker PT, Colombini M, Thompson CB (2000) Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc Natl Acad Sci USA 97:4666–4671CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Kim WH, Park WB, Gao B, Jung MH (2004) Critical role of reactive oxygen species and mitochondrial membrane potential in Korean mistletoe lectin-induced apoptosis in human hepatocarcinoma cells. Mol Pharmacol 66:1383–1396CrossRefPubMedGoogle Scholar
  42. 42.
    Rao PVL, Jayaraj R, Bhaskar ASB, Kumar O, Bhattacharya R, Saxena P, Dash PK, Vijayaraghavan R (2005) Mechanism of ricin-induced apoptosis in human cervical cancer cells. Biochem Pharmacol 69:855–865CrossRefPubMedGoogle Scholar
  43. 43.
    Aronis A, Melendez JA, Golan O, Shilo S, Dicter N, Tirosh O (2003) Potentiation of Fas-mediated apoptosis by attenuated production of mitochondria-derived reactive oxygen species. Cell Death Differ 10:335–344CrossRefPubMedGoogle Scholar
  44. 44.
    Gulzeb A (2014) Procaspase-3 activating therapeutic agents in cancer therapy. Adv Pharm Ethanomed 2:1–6CrossRefGoogle Scholar
  45. 45.
    Lyu SY, Park WB, Choi KH, Kim WH (2001) Involvement of caspase-3 in apoptosis induced by Viscum album var. coloratum agglutinin in HL-60 cells. Biosci Biotechnol Biochem 65:534–541CrossRefPubMedGoogle Scholar
  46. 46.
    Kim MS, So HS, Lee KM, Park JS, Lee JH, Moon SK, Ryu DG, Sy Chung, Jung BH, Kim YK, Moon G, Park R (2000) Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells. Gen Pharmacol Vasc Syst 34:349–355CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Ruchi Mishra
    • 1
  • Mrinal K. Das
    • 1
  • Savita Singh
    • 1
  • Radhey Shyam Sharma
    • 1
  • Sadhna Sharma
    • 2
  • Vandana Mishra
    • 1
  1. 1.Bioresources and Environmental Biotechnology Laboratory, Department of Environmental StudiesUniversity of DelhiDelhiIndia
  2. 2.Department of Zoology, Miranda House CollegeUniversity of DelhiDelhiIndia

Personalised recommendations